ADHD study: Solriamfetol Dose A vs Solriamfetol Dose B
Official title Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
ClinicalTrials.gov ID: NCT07717892
What this study is testing
What is Solriamfetol Dose A?
An investigational once‑daily capsule being studied for the treatment of ADHD in adolescents.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study will see if solriamfetol helps teens with ADHD and check its safety.
- Who it's for
- Teens aged 12 to less than 18 who have ADHD.
- What's involved
- Participants will receive either solriamfetol or a placebo for 6 weeks, with regular visits and tests to monitor effects.
- Time commitment
- The trial lasts 6 weeks and includes scheduled visits during that time.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- Male or female, aged 12 to \<18 years.
- Primary diagnosis of ADHD according to DSM-5 criteria.
- Has parents/legal guardians provide written informed consent and has child provide written informed assent to participate in the study before the...
You likely can't join if
- Unable to comply with study procedures.
- Medically inappropriate for study participation in the opinion of the investigator.
The study team makes the final eligibility decision.
Where it is enrolling
- Dothan, Alabama, United States
- Little Rock, Arkansas, United States
- Anaheim, California, United States
- Irvine, California, United States
- Long Beach, California, United States
- Los Angeles, California, United States
- Walnut Creek, California, United States
- Coral Gables, Florida, United States
- Gainesville, Florida, United States
- Jacksonville, Florida, United States
- Maitland, Florida, United States
- Orlando, Florida, United States
- Atlanta, Georgia, United States
- Bardstown, Kentucky, United States
- Owensboro, Kentucky, United States
- Springfield, Massachusetts, United States
- Worcester, Massachusetts, United States
- Jackson, Mississippi, United States
- Las Vegas, Nevada, United States
- Staten Island, New York, United States
+ 10 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Dothan, Alabama, United States; Little Rock, Arkansas, United States; Anaheim, California, United States; Irvine, California, United States; Long Beach, California, United States; Los Angeles, California, United States and 24 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.